Drugs / Antipyrine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02037893 Comparator | Nov 2013 → Sep 2014 | otitis media | Currax Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antipyrine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02037893 ↗ |
| Known as | Antipyrinum | ChEMBL registry synonym — accepted as the source's own label CHEMBL277474 ↗ |
| Known as | Fenazona | ChEMBL registry synonym — accepted as the source's own label CHEMBL277474 ↗ |
| Known as | NSC-7945 | ChEMBL registry synonym — accepted as the source's own label CHEMBL277474 ↗ |
| Known as | Phenazone | ChEMBL registry synonym — accepted as the source's own label CHEMBL277474 ↗ |
| Action | Inhibit | “Cyclooxygenase-1 inhibitor” CHEMBL277474 ↗ |
| Modality | Small molecule | — CHEMBL277474 ↗ |
| Route | Other | “Apply drops along the wall of the ear canal until filled” NCT02037893 ↗ |
| Target | PTGS1 | “Cyclooxygenase-1 inhibitor” CHEMBL277474 ↗ |